Financials OneSource Specialty Pharma Limited
Stocks
ONESOURCE
INE013P01021
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,749.70 INR | +1.06% |
|
+5.97% | -3.36% |
Projected Income Statement: OneSource Specialty Pharma Limited
| Fiscal Period: March | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Net sales 1 | - | 14,216 | 21,798 | 34,019 |
| Change | - | - | 53.34% | 56.06% |
| EBITDA 1 | - | 3,042 | 7,875 | 13,689 |
| Change | - | - | 158.87% | 73.82% |
| EBIT 1 | - | 251.3 | 5,526 | 10,322 |
| Change | - | - | 2,099.19% | 86.78% |
| Interest Paid 1 | - | -1,222 | -1,076 | -665.5 |
| Earnings before Tax (EBT) 1 | - | -919.6 | 4,031 | 9,976 |
| Change | - | - | 538.37% | 147.45% |
| Net income 1 | -179.7 | -738 | 4,459 | 8,968 |
| Change | - | -310.68% | 704.18% | 101.13% |
| Announcement Date | 5/5/25 | 5/13/26 | - | - |
1INR in Million
Estimates
Forecast Balance Sheet: OneSource Specialty Pharma Limited
| Fiscal Period: March | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Net Debt 1 | - | 11,733 | 8,856 | 1,164 |
| Change | - | - | -18.05% | -86.86% |
| Announcement Date | 5/5/25 | 5/13/26 | - | - |
1INR in Million
Estimates
Cash Flow Forecast: OneSource Specialty Pharma Limited
| Fiscal Period: March | 2026 | 2027 | 2028 |
|---|---|---|---|
| CAPEX 1 | 5,691 | 3,681 | 3,056 |
| Change | - | -16% | -16.98% |
| Free Cash Flow (FCF) 1 | -5,605 | 5,533 | 6,525 |
| Change | - | 330.96% | 17.93% |
| Announcement Date | 5/13/26 | - | - |
1INR in Million
Estimates
Forecast Financial Ratios: OneSource Specialty Pharma Limited
| Fiscal Period: March | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
Profitability | ||||
| EBITDA Margin (%) | - | 21.4% | 36.13% | 40.24% |
| EBIT Margin (%) | - | 1.77% | 25.35% | 30.34% |
| EBT Margin (%) | - | -6.47% | 18.49% | 29.32% |
| Net margin (%) | - | -5.19% | 20.46% | 26.36% |
| FCF margin (%) | - | -39.43% | 25.38% | 19.18% |
| FCF / Net Income (%) | - | 759.52% | 124.09% | 72.76% |
Profitability | ||||
| ROA | - | - | - | - |
| ROE | - | -1.26% | 6.65% | 12.52% |
Financial Health | ||||
| Leverage (Debt/EBITDA) | - | 3.86x | 1.12x | 0.09x |
| Debt / Free cash flow | - | -2.09x | 1.6x | 0.18x |
Capital Intensity | ||||
| CAPEX / Current Assets (%) | - | 40.03% | 16.89% | 8.98% |
| CAPEX / EBITDA (%) | - | 187.06% | 46.74% | 22.33% |
| CAPEX / FCF (%) | - | -101.52% | 66.53% | 46.84% |
Items per share | ||||
| Cash flow per share 1 | - | - | - | - |
| Change | - | - | - | - |
| Dividend per Share 1 | - | - | - | - |
| Change | - | - | - | - |
| Book Value Per Share 1 | - | 506.6 | 547.5 | 620.5 |
| Change | - | - | 8.06% | 13.33% |
| EPS 1 | -1.63 | -6.44 | 40.5 | 83.73 |
| Change | - | -295.09% | 511.86% | 106.75% |
| Nbr of stocks (in thousands) | 114,436 | 114,646 | 114,646 | 114,646 |
| Announcement Date | 5/5/25 | 5/13/26 | - | - |
1INR
Estimates
| 2026 | 2027 * | |
|---|---|---|
| P/E | -229x | 43.2x |
| PBR | 3.45x | 3.2x |
| EV / Sales | 12.7x | 9.61x |
| Yield | - | - |
EPS & Dividend
Y-o-Y evolution of P/E
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,749.70INR
Average target price
2,056.00INR
Spread / Average Target
+17.51%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ONESOURCE Stock
- Financials OneSource Specialty Pharma Limited
Select your edition
All financial news and data tailored to specific country editions
